BLOG / 🇺🇸 United States / broad market · · daily

Global High-Priority Regulatory Events — September 03, 2026

Global High Priority Market Events

By Gunpowder Editorial ·

42 high priority 42 total filings analysed

Executive Summary

The 42 filings reviewed for September 3, 2026, reveal a high-stakes environment dominated by SPAC activity, regulatory enforcement, and corporate distress. A clear theme is the aggressive maneuvering by SPACs to secure funding and extend deadlines, with PlusAI's $800 million merger and Ribbon Acquisition's dilutive financing standing out as high-materiality events.

The regulatory front is intense, with SEBI issuing enforcement orders for fraud and insolvency, while Nasdaq delisting actions against JFB Construction and National Healthcare Properties signal significant corporate failures. Period-over-period data is limited, but where available, it shows strong growth (e.g., Heranba's subsidiary Mikusu growing 20% YoY) and strategic capital deployment (e.g., Hillman Solutions' $315M acquisition). The overall sentiment is mixed, with pockets of opportunity in strategic M&A and turnarounds, but significant risks from regulatory actions, SPAC deadline pressures, and delisting threats. The most critical development is the wave of SPAC transactions, which could unlock value or lead to significant losses depending on execution and market reception.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · Schedule 13D

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from September 02, 2026.

Investment Signals (12)

  • PlusAI / Texas Ventures III (BULLISH)
    ▲

    SPAC merger at $800M pre-money valuation with $300M capital, targeting 2027 SuperDrive launch; revenue of $25M to date with $40-50M contracted for 2026

  • Completed $315M acquisition of Kanebridge, funded with $200M term loan B at SOFR+200bps; adds 44K SKUs and expands TAM to $3B, expected to be immediately accretive

  • Allotted ₹24.95 Cr to subsidiary Mikusu, which grew revenue 20% YoY to ₹182.68 Cr in FY25-26, indicating strong organic growth and strategic reinvestment

  • Acquiring 51% of two healthcare firms via ₹39.54 Cr share swap, signaling a pivot to high-growth IVD sector; authorized capital doubled to ₹50 Cr

  • ▲

    Regained Nasdaq compliance after 1-for-50 reverse split; stock closed above $1 for 10 consecutive days, removing delisting risk

  • Tender offer for up to 90.4M shares at NAV; 9.0% annualized return outperforming leveraged loans by 290bps, with $17B liquidity and 0.8x leverage

  • Entered highly dilutive financing (SEPA up to $100M, convertible note at 17.5% discount) to fund DRC Medicine merger; risk of severe shareholder dilution

  • Secured non-redemption agreements for up to 6.2M shares but filing notes they won't increase likelihood of extension approval; deadline pressure is high

  • ▲

    Delisting $500M perpetual capital securities (5.25% coupon) from Nasdaq, reducing liquidity for US investors and signaling a shift in capital strategy

  • ▲

    Acquired Searay Foods for CAD$47.9M, first international expansion into Canada; expected to be immediately accretive to margins and EPS, funded with cash and stock

  • ▲

    Closed acquisition of EPC contract for 123MW gas plant, advancing Project Permian to nearly 200MW total capacity; modular design enhances operational flexibility

  • Shareholders approved merger with GOWell Technology with 90.3% approval, clearing a key hurdle for the business combination

Risk Flags (10)

  • Nasdaq delisted Class A Common Stock effective Sept 3, 2026 under Rule 12d2-2(a)(3) for failing to meet listing standards; highest materiality event

  • Form 25-NSE filed to delist 7.375% Series A Preferred Stock from Nasdaq, effective Sept 3, 2026; severe liquidity reduction for preferred holders

  • Received extension to file delinquent 10-Q but remains at risk of delisting if deadline missed; ongoing delinquency signals deeper issues

  • Deceived into transferring ~$488K via fraudulent email impersonating a US provider; financial impact under assessment, management traveling to US for recovery

  • Add Life Pharma / SEBI Enforcement [HIGH RISK]
    ▼

    SEBI issued compliance notice for attachment of demat, mutual fund, and bank accounts under Recovery Certificate No. 8511/2025; serious non-compliance or outstanding dues

  • Reported only $1.78M in stockholders' equity vs $2.5M minimum; has until Oct 15, 2026 to submit compliance plan or face delisting

  • Filed Form 25-NSE to delist common stock from Nasdaq, effective Sept 3, 2026, following AbbVie merger; shareholders face liquidity loss

  • Aastha Ruia Beneficial Trust / SEBI Enforcement [MEDIUM RISK]
    ▼

    SEBI issued adjudication order for trading in illiquid stock options on BSE; regulatory scrutiny on market manipulation

  • Took $184,635 unsecured note from MACRO DREAM for one-month extension to Sept 30, 2026; tight deadline with no guarantee of completing a merger

  • Under CIRP, CoC approved resolution plan from Fairplan Distributors; outcome uncertain, shareholders likely to be wiped out

Opportunities (10)

  • PlusAI / Autonomous Trucking (OPPORTUNITY)
    ◆

    SPAC merger with Texas Ventures III at $800M pre-money; $300M capital to fund commercialization of SuperDrive; $40-50M contracted revenue for 2026; potential for significant upside if 2027 launch succeeds

  • $315M acquisition of Kanebridge adds 44K SKUs and first US master distribution platform; TAM expands to $3B; funded with manageable leverage (SOFR+200bps)

  • Acquiring 51% of two Matrix Labs entities via ₹39.54 Cr share swap; entering high-growth IVD sector; authorized capital doubled to ₹50 Cr for future expansion

  • Tender offer at NAV with 9.0% annualized return; $17B liquidity and 0.8x leverage; non-accruals declining to 2.2% at cost; attractive for income-focused investors

  • First expansion into Canada via Searay Foods acquisition (CAD$47.9M); immediately accretive to margins and EPS; sources from 80+ suppliers with six proprietary brands

  • ◆

    Closed acquisition of EPC contract for 123MW gas plant; total first-phase capacity nearly 200MW; modular design with Wärtsilä engines allows continuous operation

  • 90.3% shareholder approval for business combination with GOWell Technology; transaction expected to close, creating a new public entity in energy technology

  • Reverse stock split successfully restored bid price above $1; delisting risk removed; potential for re-rating as fundamentals improve

  • Step-down subsidiary acquired 51% of Weber Drivetrain for ₹10 Lakhs; final consideration revised down 93% from initial ₹1.43 Cr, suggesting favorable terms

  • NCLT dispensed with shareholder and creditor meetings for Inzpera Healthsciences merger; procedural step forward in streamlining corporate structure

Sector Themes (6)

  • SPAC Deadline Pressure and Dilutive Financing
    ◆

    Multiple SPACs (Andretti II, Ribbon, Wintergreen) are securing non-redemption agreements and high-cost loans to extend deadlines, indicating a wave of last-minute deals or liquidations. Ribbon's SEPA at 17.5% discount and Andretti's non-redemption agreements highlight the extreme measures being taken to preserve trust funds.

  • Regulatory Enforcement Surge
    ◆

    SEBI and Nasdaq are actively enforcing compliance, with multiple delistings (JFB Construction, National Healthcare, Apogee) and fraud investigations (Add Life Pharma, Sunsky Logistics). This suggests a tightening regulatory environment that could lead to more corporate failures.

  • Strategic M&A in Niche Markets
    ◆

    Hillman Solutions (industrial fasteners), HF Foods (ethnic frozen seafood), and One Global Service Provider (healthcare/IVD) are making bolt-on acquisitions to expand into adjacent markets. These deals are immediately accretive and funded with manageable leverage or share swaps.

  • Autonomous Vehicle and Energy Transition Deals
    ◆

    PlusAI's SPAC merger and Net Power's Project Permian acquisition signal continued investor interest in high-growth, capital-intensive sectors. Both have clear commercialization timelines (2027 for PlusAI, near-term for Net Power) and significant institutional backing.

  • Private Credit and BDC Tender Offers
    ◆

    Blackstone Private Credit Fund and Keystone Private Income Fund are conducting tender offers at NAV, providing liquidity to investors. Blackstone's 9.0% return and low leverage (0.8x) contrast with the broader market volatility, making it a relative safe haven.

  • Insider and Sponsor Activity in SPACs
    ◆

    JATT III Acquisition Corp's Schedule 13D reveals sponsor and director ownership of 22.1% with a $2.34M private placement, indicating strong alignment. However, the filing states no current plans for a merger, suggesting a patient approach to finding a target.

Watch List (10)

Filing Analyses (42)
Crown PropTech Acquisitions 8-K neutral materiality 8/10

03-09-2026

Crown PropTech Acquisitions (CPTKW) has entered into an amended and restated business combination agreement with Mkango Rare Earths Limited and its subsidiaries, dated September 2, 2026. The transaction involves a merger where Mkango (Cayman) Limited will merge into Crown PropTech, with Mkango BVI becoming the public company (PubCo). The deal includes a pre-closing reorganization, share adjustments, and various covenants related to mining licenses, debt-to-equity exchanges, and offtake arrangements. No financial figures or period-over-period comparisons are provided in this filing.

  • · The agreement amends and restates a prior business combination agreement (Original Agreement).
  • · Mkango BVI will become PubCo after closing.
  • · The transaction includes a Shareholder Support Agreement and Sponsor Support Agreement.
  • · Conditions include a Minimum Cash Condition and regulatory approvals.
  • · The agreement includes provisions for a PubCo Incentive Plan and D&O indemnification.
  • · OTC Markets quotation is referenced for SPAC securities.
  • · The filing does not disclose the equity value or any financial terms of the transaction.
Max Healthcare Institute Limited Merger/Acquisition neutral materiality 5/10

03-09-2026

Max Healthcare Institute Limited's RESIC approved an infusion of ~₹87.87 Crore into its subsidiary Kalinga Hospital Ltd. via a rights issue of equity shares. The funds will support KHL's capital expenditure, modernization, and general corporate requirements. The transaction is a related party transaction but exempt under SEBI LODR regulations, and no promoter/group entities have an interest in KHL.

  • · The RESIC meeting commenced at 2:50 PM IST and concluded at 3:22 PM IST on September 3, 2026.
  • · The acquisition is expected to be completed within the next 15 days.
  • · Kalinga Hospital Ltd. is an existing subsidiary of Max Healthcare Institute Limited.
  • · The infusion is exempt from related party transaction provisions under SEBI LODR Regulations.
Alchemy Investments Acquisition Corp 1 8-K neutral materiality 3/10

03-09-2026

Alchemy Investments Acquisition Corp 1 held an extraordinary general meeting on September 1, 2026, where shareholders approved a proposal to adjourn the meeting. The meeting will reconvene on September 4, 2026, and the company is continuing to accept requests from shareholders to reverse previously submitted redemption elections.

  • · The meeting was adjourned to Friday, September 4, 2026 at 10:00 a.m. Eastern Time.
  • · Shareholders can attend in person at Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154, or virtually at https://www.cstproxy.com/alchemyinvest/2026.
  • · Shareholders seeking to reverse redemption elections should contact their broker or Continental Stock Transfer & Trust Company.
Texas Ventures Acquisition III Corp 8-K mixed materiality 9/10

03-09-2026

PlusAI, a developer of AI-based virtual driver software for autonomous trucks, will go public via a merger with SPAC Texas Ventures Acquisition III Corp at an $800 million pre-money valuation. The deal brings up to ~$300 million in capital ($60M+ committed financing plus ~$236M trust) to fund commercialization. PlusAI has generated $25M in revenue to date and targets $40-50M in contracted revenue for 2026, but remains pre-commercial for its core SuperDrive product, with a targeted 2027 launch.

  • · PlusAI is actively operating autonomous freight routes in Texas with Ryder and International.
  • · The transaction has been unanimously approved by the boards of both companies and is expected to close in 2026.
  • · Existing PlusAI stockholders, the Texas Ventures III sponsor and insiders will be subject to lock-up agreements post-closing.
  • · The combined company will continue to operate as PlusAI after closing.
  • · PlusAI was named one of Fast Company's World's Most Innovative Companies.
  • · The SPAC is a Cayman Islands entity and may pursue an acquisition in any business or geography.
Ribbon Acquisition Corp. 8-K mixed materiality 9/10

03-09-2026

Ribbon Acquisition Corp. entered into a series of financing agreements with Meteora Select Trading Opportunities Master, LP in connection with its pending business combination with DRC Medicine Ltd. The agreements include a Forward Purchase Agreement for up to 4,100,000 shares, a Standby Equity Purchase Agreement (SEPA) for up to $100,000,000, and a $1,212,121 convertible promissory note (issued at a 17.5% discount). While the financing provides substantial liquidity for the merger, the terms are highly dilutive to existing shareholders, with the Investor receiving a 1.75% commitment fee ($1,750,000), a 7% payment premium on the note, and conversion prices as low as 95% of the lowest VWAP over five days.

  • · The Forward Purchase Agreement allows the Investor to purchase up to 4,100,000 shares of PubCo common stock at the per-share redemption price.
  • · The per-share reference price resets weekly after the first 30 days to the lower of $10.00 and the prior week's VWAP.
  • · The SEPA has no minimum usage requirement and no fee on unused commitment.
  • · The Note bears no interest absent an event of default, at which point it accrues at 18% per annum.
  • · Upon closing, certain PubCo shareholders will deposit 9.9% of outstanding Common Shares into escrow.
  • · The Investor has a right of first refusal on up to 33% of future financings for six months after the valuation date.
  • · The Note requires 33% of net proceeds from most financings to be applied to repayment of outstanding principal.
Andretti Acquisition Corp. II 8-K mixed materiality 7/10

03-09-2026

Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors on September 1-2, 2026, to secure commitments not to redeem up to 2,200,000 public shares in exchange for up to 550,000 Pubco shares (if a business combination closes by June 9, 2027) or up to an additional 183,334 Pubco shares (if closed after that date). These agreements, combined with prior agreements covering up to 3,600,000 non-redeemed shares, aim to increase trust account funds ahead of the September 8, 2026 special meeting to extend the business combination deadline to September 9, 2027. However, the filing notes the agreements are not expected to increase the likelihood of shareholder approval for the extension, and the company faces ongoing risks including potential failure to consummate a business combination.

  • · The special meeting was originally convened on August 28, 2026, then adjourned to September 8, 2026 at 10:00 a.m. Eastern Time.
  • · The non-redemption agreements terminate upon the earliest of: failure to approve extension, company determination not to proceed, fulfillment of obligations, liquidation/dissolution, mutual written agreement, or if the investor exercises redemption rights and shares are actually redeemed.
  • · The company is a blank check (SPAC) company incorporated in the Cayman Islands, with securities traded on Nasdaq under symbols POLEU, POLE, and POLEW.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
Fractal Analytics Ltd Insolvency neutral materiality 3/10

03-09-2026

Fractal Analytics Ltd has disclosed the voluntary liquidation of its step-down subsidiary, Fractal Analytics Sweden AB, effective July 15, 2026. The liquidation was carried out to simplify the group's corporate structure, reduce administrative costs, and streamline legal and regulatory compliance. The company stated that the liquidation has no financial benefit to the promoter or promoter group, and the company's shareholding pattern remains unchanged.

  • · The liquidation was effective from July 15, 2026.
  • · The company received intimation from the liquidator on September 2, 2026.
  • · The liquidation is part of a group restructuring to reduce administrative costs and compliance burdens.
  • · The company's shareholding pattern remains unchanged.
Cipla Limited Insolvency neutral materiality 5/10

03-09-2026

Cipla Limited has issued statutory notices to shareholders and unsecured creditors regarding the Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited into Cipla, following an NCLT order dated 18th August 2026. The NCLT has dispensed with meetings of equity shareholders and unsecured creditors, but allows representations within 30 days. This is a procedural step in the merger process, with no financial figures disclosed.

  • · NCLT order dated 18th August 2026 (C.A. (CAA)/ 114 (MB)/ 2026) dispensed with meetings of equity shareholders and unsecured creditors.
  • · No secured creditors exist in the Transferee Company, so no secured creditor meeting is required.
  • · Representations must be submitted to NCLT within 30 days from receipt of notice; silence implies no objection.
  • · Notices sent via electronic and physical modes to shareholders and creditors.
Hillman Solutions Corp. 8-K positive materiality 8/10

03-09-2026

Hillman Solutions Corp. completed its acquisition of Kanebridge, LLC for approximately $315 million, funded through cash, a draw on its asset-based credit facility, and a new $200 million term loan B at SOFR plus 200 bps. The deal adds over 44,000 industrial fastener SKUs and expands Hillman's industrial addressable market to about $3 billion, marking its first U.S. master distribution platform in the industrial fastener market. While the acquisition is strategically positioned to benefit from secular tailwinds and diversify the customer base, it carries integration risks and the company faces ongoing headwinds from inflation, supply chain costs, and customer concentration.

  • · Acquisition was first announced on August 3, 2026.
  • · Kanebridge has been a master distributor for more than 50 years with warehouses in Illinois and California offering same-day shipment.
  • · Hillman was founded in 1964 and has over 60 years of history.
  • · The company filed an 8-K with Items 1.01, 2.01, 8.01, and 9.01.
SHREE HANUMAN SUGAR & INDUSTRIES LTD. Insolvency materiality 6/10

03-09-2026

TVS Srichakra Limited Merger/Acquisition neutral materiality 5/10

03-09-2026

TVS Srichakra Limited announced that its step-down wholly-owned subsidiary, TVS Sensing Solutions Private Limited, has completed the acquisition of a 51% equity stake in Weber Drivetrain Private Limited for a total consideration of ₹10,00,000. The transaction was completed on August 31, 2026, making Weber a step-down subsidiary of TVS Srichakra. The final consideration was revised downward from the initially disclosed ₹1,43,00,000, and the company cited a delay in disclosure due to verification of transaction particulars.

  • · The acquisition was completed on August 31, 2026, with 100% of the transaction completed.
  • · The final consideration of ₹10,00,000 is a significant downward revision from the initially disclosed ₹1,43,00,000.
  • · The company acknowledged a delay in disclosure due to verification of transaction particulars and preparation of the corrected filing.
  • · Weber Drivetrain Private Limited has become a step-down subsidiary of TVS Srichakra Limited effective August 31, 2026.
Unknown SEBI Enforcement negative materiality 6/10

03-09-2026

SEBI issued an adjudication order against Aastha Ruia Beneficial Trust for trading in illiquid stock options on the BSE. The order was published on September 3, 2026, under the enforcement actions of the Securities and Exchange Board of India.

  • · The order is an adjudication order from SEBI's Office of AO (Adjudicating Officer) Enforcement.
  • · The matter specifically involves trading in illiquid stock options at BSE.
  • · The entity penalized is Aastha Ruia Beneficial Trust.
Unknown Fraud Investigation negative materiality 8/10

03-09-2026

SEBI has issued an order for compliance notice of attachment of demat account and mutual fund folio(s) against Add Life Pharma Ltd under Recovery Certificate No.8511 of 2025. This regulatory action indicates ongoing enforcement proceedings for recovery of dues by the securities regulator.

  • · Recovery Certificate No.8511 of 2025 is the basis for the attachment order.
  • · The order targets both demat accounts and mutual fund folio(s) of the company.
  • · The filing is categorized under SEBI's Recovery Proceedings enforcement section.
Unknown Fraud Investigation negative materiality 9/10

03-09-2026

SEBI has issued a compliance notice for attachment of bank/post office accounts against Add Life Pharma Ltd under Recovery Certificate No. 8511 of 2025, indicating an escalation in recovery proceedings. This regulatory action signals serious non-compliance or outstanding dues, which may negatively impact the company's financial standing and operational liquidity.

  • · Recovery Certificate No. 8511 of 2025 is the basis for the attachment order.
  • · The notice specifically targets bank and post office accounts of the company.
  • · The filing date is September 03, 2026, and the matter is under SEBI's Recovery Proceedings.
BIL VYAPAR LIMITED Insolvency neutral materiality 8/10

03-09-2026

BIL Vyapar Limited (formerly Binani Industries Limited), currently under Corporate Insolvency Resolution Process (CIRP), has disclosed that its Committee of Creditors (CoC) has approved the resolution plan submitted by Fairplan Distributors Pvt Ltd. This marks a key step in the insolvency proceedings, though the specific financial terms of the plan were not disclosed.

  • · The company is currently under Corporate Insolvency Resolution Process (CIRP).
  • · The resolution plan was approved by the Committee of Creditors (CoC).
  • · The approved resolution plan is from Fairplan Distributors Pvt Ltd.
  • · No financial details (e.g., plan value, haircut, timeline) were disclosed in the filing.
Heranba Industries Limited Merger/Acquisition positive materiality 6/10

03-09-2026

Heranba Industries Limited has allotted 2,49,50,000 partly paid-up equity shares of ₹10 each at par to its material wholly owned subsidiary Mikusu India Private Limited for an aggregate consideration of ₹24,95,00,000 (₹24.95 Crore). The investment, approved by the Board on August 22, 2026, is intended to support Mikusu's business operations and growth. Notably, Mikusu's turnover has grown steadily from ₹92.91 Crore in FY 2023-24 to ₹182.68 Crore in FY 2025-26, representing a strong 20% YoY increase in the latest fiscal year.

Kenrik Industries Limited Open Offer neutral materiality 1/10

03-09-2026

The filing is a copy of a filing, but it is garbled and contains no interpretable financial or business data. No concrete information about an open offer, such as target company, offer price, or timeline, can be extracted.

Sunsky Logistics Limited Fraud Investigation negative materiality 8/10

03-09-2026

Sunsky Logistics disclosed a cyber fraud incident on September 3, 2026, where it was deceived into transferring approximately USD 4,88,000 to an unauthorized bank account after receiving a fraudulent email impersonating a long-standing U.S. service provider. The company has initiated an internal investigation, is filing complaints with authorities, and is strengthening internal controls, though the financial and operational impact remains under assessment.

  • · The fraud occurred on Wednesday, September 2, 2026.
  • · No company personnel are suspected of involvement; the fraud appears perpetrated by unidentified external individuals.
  • · Management is traveling to the USA to pursue fund recovery and legal remedies with an attorney.
  • · No company-wide business disruption has been identified as of the disclosure date.
  • · The company is filing a formal complaint with regulatory and law enforcement authorities.
Spentex Industries Ltd Insolvency neutral materiality 3/10

03-09-2026

CLC Industries Ltd has submitted applications to BSE (Jan 28, 2026) and NSE (Apr 29, 2026) seeking reclassification of its erstwhile promoters/promoter group to the public category, pursuant to an NCLT-approved resolution plan (May 12, 2023). The company received a query from NSE (Sept 1, 2026) regarding applicability of SEBI LODR regulations and is complying. All nine erstwhile promoter entities hold zero shares, indicating no change in shareholding.

  • · NCLT Order dated May 12, 2023 approved the Resolution Plan for CLC Industries.
  • · Board noted the Promoter Re-classification in its meeting held on January 22, 2026.
  • · NSE query letter No. NSE/LIST/588 dated September 1, 2026 regarding applicability of Regulation 31A(2) & 8(c) of SEBI LODR.
  • · Applications submitted to BSE on January 28, 2026 and to NSE on April 29, 2026.
  • · All erstwhile promoter entities hold 0 shares (Nil holding).
ONE GLOBAL SERVICE PROVIDER LIMITED Merger/Acquisition positive materiality 8/10

03-09-2026

One Global Service Provider Limited (formerly Overseas Synthetics) has approved the acquisition of 51% equity stakes in Matrix Labs Diagnocare Private Limited (MLDPL) and Matrix Labs Private Limited (MLPL) for a total non-cash consideration of ₹39,54,17,120, to be discharged via a preferential share swap. The board also appointed M/s. S D P M & Co as statutory auditors for a second term, M/s. Valawat & Associates as internal auditors for FY26-27, increased authorized share capital from ₹25,05,00,000 to ₹50,00,00,000, and convened the 34th AGM for September 29, 2026. The acquisitions aim to strengthen the company's presence in the healthcare and IVD sector, though they are subject to shareholder and regulatory approvals.

  • · The board meeting commenced at 5:00 PM and concluded at 11:15 PM on September 3, 2026.
  • · The appointment of M/s. S D P M & Co as statutory auditors is for a second term of 5 consecutive years from the conclusion of the 34th AGM to the 39th AGM, subject to member approval.
  • · M/s. Valawat & Associates was appointed as internal auditors for FY 2026-27 following the resignation of M/s. Rushil Soni & Co on August 14, 2026.
  • · The 34th Annual General Meeting is scheduled for September 29, 2026, at 2:00 PM via video conferencing/other audio-visual means.
  • · The acquisitions are not related party transactions and the promoter/promoter group/group companies have no interest in the target entities.
N2OFF, Inc. 8-K negative materiality 8/10

03-09-2026

Nexentis Technologies Inc. (NITO) received a Nasdaq Staff deficiency letter on August 31, 2026, for failing to meet the minimum stockholders' equity requirement of $2,500,000 for continued listing, reporting only $1,782,000 as of June 30, 2026. The company has until October 15, 2026, to submit a compliance plan, and if accepted, may receive an extension through February 27, 2027. While there is no immediate impact on listing, failure to regain compliance could lead to delisting, though the company can request a hearing to stay any delisting action.

  • · Company has 45 calendar days from the letter (until October 15, 2026) to submit a compliance plan.
  • · If compliance plan is accepted, Nasdaq may grant an extension of up to 180 calendar days through February 27, 2027.
  • · If the compliance plan is not accepted or compliance not regained, a delisting determination would be issued, but the company can request a hearing before a Nasdaq Hearings Panel to stay delisting.
  • · The deficiency is based on the company's Form 10-Q for the period ended June 30, 2026.
  • · The letter has no immediate impact on the listing of the company's common stock.
National Healthcare Properties, Inc. 25-NSE negative materiality 8/10

03-09-2026

National Healthcare Properties, Inc. (NHPBP) filed a Form 25-NSE with the SEC on September 3, 2026, to delist its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock from the Nasdaq Stock Market. The delisting is effective as of the filing date and is based on SEC Rule 17 CFR 240.12d2-2(a)(2), which typically applies when the exchange removes the security from listing. This action represents a significant corporate event that will reduce liquidity and market access for the preferred stock.

  • · The delisting is effective as of September 3, 2026.
  • · The filing was made by Nasdaq Stock Market LLC, not the company itself.
  • · The security being delisted is the 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (ticker NHPBP).
  • · The delisting is under SEC Rule 17 CFR 240.12d2-2(a)(2), which allows the exchange to remove a security from listing.
  • · The company's SEC file number is 001-39153.
  • · The company was formerly known as Healthcare Trust, Inc. (name change in 2015) and American Realty Capital Healthcare Trust II, Inc. (name change in 2012).
GULF RESOURCES, INC. 8-K negative materiality 9/10

03-09-2026

Gulf Resources received an extension from Nasdaq to regain compliance with Listing Rule 5250(c)(1) by filing its delinquent Form 10-Q for the quarter ended June 30, 2026. The company remains non-compliant and faces potential delisting if it fails to meet the extended deadline. While the extension provides temporary relief, the ongoing delinquency and risk of delisting represent significant negative developments for shareholders.

  • · The company received a Deficiency Letter from Nasdaq on August 24, 2026, for failure to timely file the June 30th Form 10-Q.
  • · The Extension Letter requires the company to file the delinquent June 30th Form 10-Q by the applicable extended deadline.
  • · If the company fails to evidence compliance, Nasdaq staff will notify the company that its securities will be subject to delisting, with a possible appeal to a hearings panel.
  • · The company remains delinquent in filing the June 30th Form 10-Q as of the date of this report.
  • · The company had previously resolved its delinquency for the March 31, 2026 Form 10-Q.
NET Power Inc. 8-K positive materiality 7/10

03-09-2026

Net Power Inc. closed the acquisition of EMPower's contractual rights under an EPC agreement for a 123 MW reciprocating-engine natural gas power generation facility, advancing its Project Permian in West Texas. The transaction, announced on August 24 and closed on August 31, 2026, brings Net Power's total potential capacity for the first phase to nearly 200 MW. Saulsbury remains the EPC contractor, and Wärtsilä will supply ten engine-generator sets.

  • · The acquired EPC agreement includes rights and benefits under the related equipment-supply agreement for the ten engine-generator sets.
  • · The facility is designed for fast-start operation and can ramp output up and down to follow variable load.
  • · The ten-unit modular configuration allows individual engines to be serviced without taking the full facility offline.
  • · Saulsbury will serve as turnkey EPC contractor for engineering, procurement, construction, commissioning, and start-up.
  • · The transaction closed 18 days after the initial announcement.
Wintergreen Acquisition Corp. 8-K mixed materiality 6/10

03-09-2026

Wintergreen Acquisition Corp. (WTGUR) entered into an unsecured promissory note for $184,635 with MACRO DREAM Holdings Limited to fund a one-month extension of its business combination deadline from August 30, 2026, to September 30, 2026. The note bears no interest and is convertible into units at $10.00 per unit upon a business combination, but is fully forgiven if no deal closes and the company liquidates. This extension loan signals the company is still pursuing a merger but faces a tight deadline with no guarantee of completion.

  • · The note is unsecured and bears no interest.
  • · Proceeds must be deposited into the trust account to fund the extension.
  • · Conversion is at Payee's option, limited to $1,500,000 aggregate for similar loans.
  • · If no business combination occurs by September 30, 2026, the note is forgiven and Payee has no claim on trust account.
  • · The same individual, Yongfang Yao, signed for both Maker and Payee, indicating a related-party transaction.
JFB Construction Holdings 25-NSE negative materiality 10/10

03-09-2026

JFB Construction Holdings (JFB) received a delisting notice filed by Nasdaq Stock Market LLC via SEC Form 25-NSE, effective September 3, 2026. The delisting is based on 17 CFR 240.12d2-2(a)(3), which relates to the exchange's determination that the company no longer meets listing requirements. The filing triggers the removal of the company's Class A Common Stock from Nasdaq.

  • · Delisting effective date: September 3, 2026
  • · Regulation cited: 17 CFR 240.12d2-2(a)(3) (exchange-initiated delisting for failure to meet listing standards)
  • · Security affected: Class A Common Stock
  • · Filing submitted by Nasdaq on behalf of the exchange
VODAFONE GROUP PUBLIC LTD CO 25-NSE negative materiality 6/10

03-09-2026

Vodafone Group Public Ltd Co has filed a Form 25-NSE with the SEC on September 3, 2026, to delist its U.S.$500,000,000 NC 5.25 Capital Securities Due 2081 from the Nasdaq Stock Market. The delisting is effective as of the filing date and is made under SEC Rule 17 CFR 240.12d2-2(a)(1), which typically applies when the issuer has certified that the securities are no longer listed on the exchange. This action removes the security from Nasdaq listing, potentially reducing liquidity and visibility for U.S. investors.

  • · The delisting is effective immediately on September 3, 2026.
  • · The filing is made under SEC Rule 17 CFR 240.12d2-2(a)(1), indicating the issuer has certified the securities are no longer listed on Nasdaq.
  • · The security is a perpetual capital instrument (due 2081) with a 5.25% coupon, non-callable for 5 years (NC 5.25).
  • · The delisting applies only to this specific debt security, not to Vodafone's ordinary shares or other listed securities.
Inflection Point Acquisition Corp. V 8-K positive materiality 8/10

03-09-2026

Inflection Point Acquisition Corp. V (IPEXU) shareholders approved the business combination with GOWell Technology Limited at an extraordinary general meeting on September 3, 2026, with 9,073,774 votes for and 976,157 against (90.3% approval). All related proposals, including the merger plan, advisory organizational documents, and the 2026 Equity Incentive Plan, were also approved. The transaction will result in the SPAC merging into PubCo (GOWell Energy Technology) and Merger Sub merging into GOWell, with PubCo as the surviving entity.

  • · The Business Combination Agreement was originally signed on October 13, 2025, and amended on December 22, 2025 and July 13, 2026.
  • · The proxy statement was filed with the SEC on August 12, 2026.
  • · The registration statement was declared effective by the SEC on August 11, 2026.
  • · The Adjournment Proposal was not needed and no vote was called on it.
  • · The PubCo A&R Articles authorize 500,000,000 shares (450,000,000 ordinary shares and 50,000,000 preferred shares).
  • · The GOWell Shareholder (Hegro Well PTE. Ltd.) can appoint 50% of PubCo's board if it holds at least 40% of shares.
  • · Inflection Point Fund I LP and another investor have consent rights over certain actions if they hold at least 20% of PubCo Preferred Shares.
JATT III Acquisition Corp SC 13D neutral materiality 5/10

03-09-2026

JATT Ventures III L.P. and Dr. Someit Sidhu filed a Schedule 13D disclosing beneficial ownership of 1,959,000 ordinary shares (22.1%) of JATT III Acquisition Corp, a blank-check company. The shares were acquired through founder shares purchased for $25,000 (later forfeited in part) and a private placement of 234,000 shares for $2,340,000 at the IPO on August 27, 2026. The filing indicates no current plans for a merger, reorganization, or other extraordinary transaction, but the sponsor and Dr. Sidhu are actively pursuing a business combination target.

  • · Founder shares were originally 2,156,250, but 431,250 were forfeited on July 6, 2026, leaving 1,725,000.
  • · The private placement of 234,000 shares closed simultaneously with the IPO on August 27, 2026.
  • · Placement shares are subject to a lock-up until 30 days after the completion of the initial business combination.
  • · The reporting persons have sole voting and dispositive power over all 1,959,000 shares.
  • · No transactions in the issuer's ordinary shares were effected by the reporting persons in the 60 days prior to the filing date.
Rainier Acquisition Corp 8-K positive materiality 8/10

03-09-2026

Rainier Acquisition Corp completed its IPO of 7,500,000 units at $10.00 per unit on August 26, 2026, and subsequently closed the full over-allotment of 1,125,000 additional units on September 2, 2026, generating total gross proceeds of $86.25 million. Simultaneously with the over-allotment closing, the company issued 5,625 private placement units to its sponsor at $10.00 per unit, bringing total private placement units to 200,000. The proceeds are held in a trust account for the benefit of public shareholders as the company seeks an initial business combination.

  • · The company is a Cayman Islands exempted company with its principal executive offices in New York, NY.
  • · The company is an emerging growth company as defined under the Securities Act.
  • · Private Placement Warrants are non-redeemable and may be exercised on a cashless basis only if held by the sponsor.
  • · Private Placement Units and underlying shares are not transferable or salable until 30 days after completion of the initial business combination.
  • · No underwriting discounts or commissions were paid on the private placement.
  • · The private placement was exempt from registration under Section 4(a)(2) of the Securities Act.
  • · The audited balance sheet as of August 28, 2026, is included as Exhibit 99.1.
Fly-E Group, Inc. 8-K neutral materiality 5/10

03-09-2026

Fly-E Group, Inc. received a Nasdaq deficiency notice on September 1, 2026, for failing to timely file its Form 10-Q for the period ended June 30, 2026, in violation of Listing Rule 5250(c)(1). However, the company filed the delinquent 10-Q on the same day and received written confirmation of compliance from Nasdaq on September 3, 2026, resolving the issue with no immediate impact on listing or trading.

  • · The deficiency notice was issued under Nasdaq Listing Rule 5250(c)(1) for late filing of Form 10-Q.
  • · The Form 10-Q was filed on September 1, 2026, the same day the notice was received.
  • · Nasdaq confirmed compliance on September 3, 2026, after the filing.
  • · The notice had no immediate effect on the listing or trading of FLYE shares on the Nasdaq Capital Market.
  • · The company issued a press release on September 3, 2026, announcing the receipt and resolution of the notice.
Soulpower Acquisition Corp. 8-K mixed materiality 8/10

03-09-2026

Soulpower Acquisition Corp. (SPAC) entered into a Second Amendment to its Business Combination Agreement with SWB Holdings (Pubco) and SWB LLC (Company), amending the merger consideration structure and extending the outside date to April 2, 2027. The amendment revises the merger consideration to 120% of Company Net Asset Amount plus 20% of the Uruguay Contribution Amount and $60 million for the Put Option Amount, while also requiring a minimum Company Net Asset Amount of $250 million at closing. The deal involves contributions of real estate, mineral rights, and other assets from investors, with a separate Uruguay Contribution Agreement providing for up to 111.5 million earnout shares and $5 million in cash.

  • · The amendment deletes the concept of 'Additional Contribution Agreements' and replaces references with the Uruguay Contribution Agreement specifically.
  • · The Uruguay Contribution Agreement involves entities Bisland SA and Los Naranjos SA in Uruguay.
  • · The Merger Consideration includes a Put Option Amount of $60 million allocated solely to Carident.
  • · The Outside Date for the business combination has been extended from nine months after signing (November 24, 2025) to April 2, 2027.
  • · The Company Net Asset Amount definition now includes amounts paid for a BVI Banking License and under the Advisory Agreement, and excludes obligations for Uruguay Shares.
Andretti Acquisition Corp. II 8-K neutral materiality 5/10

03-09-2026

Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors on September 3, 2026, to secure commitments not to redeem up to 448,959 Public Shares in exchange for up to 112,240 Pubco Shares (if a business combination closes by June 9, 2027) or up to 149,653 Pubco Shares (if closed after that date). These agreements supplement prior non-redemption agreements covering up to 5,800,000 Non-Redeemed Shares. The company is seeking shareholder approval to extend its business combination deadline from September 9, 2026 to September 9, 2027, but the non-redemption agreements are not expected to increase the likelihood of the extension being approved.

  • · The non-redemption agreements are not expected to increase the likelihood that the Extension is approved by shareholders, but are expected to increase the amount of funds remaining in the trust account.
  • · The Special Meeting was adjourned from August 28, 2026 to September 8, 2026 to allow more time for redemptions and reversal of redemptions.
  • · The non-redemption agreements terminate upon the earliest of: failure to approve Extension, Company determination not to proceed, fulfillment of all obligations, liquidation/dissolution, mutual written agreement, or if the Investor exercises redemption rights and shares are actually redeemed.
CXApp Inc. 8-K positive materiality 8/10

03-09-2026

CXApp Inc. (CXAIW) received a Nasdaq compliance letter on September 2, 2026, confirming that its Class A Common Stock has regained compliance with the minimum $1.00 bid price requirement (Listing Rule 5550(a)(2)). The company had been notified of non-compliance on September 11, 2025, and was granted two 180-day cure periods, the second expiring September 7, 2026. After effecting a 1-for-50 reverse stock split on August 18, 2026, the stock's closing bid price remained at or above $1.00 for 10 consecutive business days, leading to the closure of the delisting matter.

  • · The initial non-compliance notification was received on September 11, 2025.
  • · The first compliance period ended March 10, 2026; a second 180-day extension was granted on March 11, 2026, expiring September 7, 2026.
  • · The reverse stock split was effected on August 18, 2026.
  • · The compliance confirmation letter from Nasdaq is dated September 2, 2026.
  • · The company issued a press release on September 3, 2026, announcing the regained compliance.
Blackstone Private Credit Fund SC TO-I/A mixed materiality 8/10

03-09-2026

Blackstone Private Credit Fund (BCRED) filed an amendment to its tender offer to repurchase up to 90,421,330 shares at NAV as of September 30, 2026. The fund reported a 9.0% annualized total net return for Class I shares since inception, outperforming leveraged loans by ~290 bps, and pays a 9.1% annualized distribution rate. However, Q3 repurchase requests were an estimated $4.3 billion (~10% of shares outstanding), while the fund will only fulfill 5% of shares outstanding, leaving a significant backlog. Net outflows were ~3% of NAV, in line with prior quarters, and non-accruals declined to 2.2% at cost and 1.1% at fair value.

  • · The fund has over $17 billion of available liquidity as of June 30, 2026.
  • · Leverage remains modest at 0.8x debt-to-equity as of July 31, 2026.
  • · The portfolio is marked at 95.4, in line with broadly syndicated loans.
  • · The bottom 5% of the private debt portfolio is marked at 63.4.
  • · LTM EBITDA growth across borrowers is 10%, with software borrowers outperforming.
  • · Interest coverage improved 45% since Q1 2024 to 2.3x as of Q2 2026.
  • · PIK income as a percentage of total investment income declined 20% since Q1 2026 to 5.6% in Q2 2026.
  • · Non-accruals declined from Q1 2026 levels to 2.2% at cost and 1.1% at fair value.
  • · The fund deployed over $6 billion in H1 2026 into primarily first-lien senior secured positions.
  • · Capital inflows during Q3 were approximately 2% of NAV, resulting in a net outflow of approximately 3% of NAV.
  • · Loan repayments of $2.7 billion in Q2 and nearly $750 million of inflows in Q3 are together expected to represent approximately 160% of shares repurchased this quarter.
  • · The annualized repayment rate is approximately 14%.
HF Foods Group Inc. 8-K positive materiality 8/10

03-09-2026

HF Foods Group Inc. completed its acquisition of Searay Foods Inc., a Canadian importer and distributor of ethnic frozen seafood, for a base purchase price of approximately CAD$47.9 million (US$35.0 million). The deal marks HF Foods' first international expansion into Canada and is expected to be immediately accretive to margins and EPS. The acquisition was funded with CAD$38.4 million in cash and 1.7 million shares of HF Foods common stock, with additional contingent consideration based on future performance.

  • · Searay was founded in 2000 and is headquartered in Richmond, British Columbia.
  • · Searay sources from over 80 suppliers worldwide and distributes through six proprietary brands.
  • · The acquisition is expected to be immediately accretive to HF Foods' margins and EPS.
  • · Searay's existing management team, led by Derick Ngan, will continue to run day-to-day operations as a subsidiary.
Apogee Therapeutics, Inc. 8-K neutral materiality 6/10

03-09-2026

Apogee Therapeutics, Inc. has entered into an Agreement Regarding Parachute Payments with certain executives in connection with its pending acquisition by AbbVie Inc. under a Merger Agreement dated June 18, 2026. The agreement provides for gross-up payments to cover any excise taxes under Section 280G/4999 of the Internal Revenue Code, capped at $12.5 million in aggregate for all covered executives. The agreement automatically terminates if the merger is not consummated.

  • · The Merger Agreement was signed on June 18, 2026.
  • · The gross-up payment cap of $12.5 million applies to the aggregate of all payments under similar agreements with individuals named in Section 5.2(b)(v) of the Company Disclosure Schedule.
  • · The agreement requires the executive to execute a Restrictive Covenant Agreement (RCA) as a condition.
  • · If the Merger Agreement is terminated prior to closing, this agreement automatically terminates and is void ab initio.
  • · The agreement is governed by Delaware law.
Plutonian Acquisition Corp. II 8-K neutral materiality 5/10

03-09-2026

Plutonian Acquisition Corp. II, a SPAC, announced on September 3, 2026, that it has entered into a definitive merger agreement with NT1 Pty Ltd, an Australian mineral exploration company. The transaction is expected to result in a combined company listed on the New York Stock Exchange. No financial terms, valuation, or performance metrics were disclosed in this filing.

  • · The merger agreement is between Plutonian Acquisition Corp. II (a SPAC) and NT1 Pty Ltd (an Australian mineral exploration company).
  • · The combined company will be listed on the New York Stock Exchange.
  • · The transaction requires shareholder approval from both Plutonian II and NT1.
  • · A registration statement on Form F-4 will be filed with the SEC, including a proxy statement/prospectus.
  • · Plutonian II's IPO prospectus was dated April 28, 2026.
  • · No financial terms, valuation, or deal size were disclosed in this filing.
Keystone Private Income Fund SC TO-I/A neutral materiality 5/10

03-09-2026

Keystone Private Income Fund filed a final amendment to its Schedule TO, reporting the results of its issuer tender offer that expired on February 27, 2026. The Fund accepted valid tenders from 433 shareholders, purchasing shares across four classes (D, Y, I, Z) with an aggregate net asset value of approximately $99.4 million, up to the maximum of $88.8 million. Payments were made on April 17, 2026, based on unaudited NAV as of March 31, 2026.

  • · The tender offer was originally filed on January 29, 2026, and expired on February 27, 2026.
  • · All 433 shareholders who validly tendered shares had their tenders accepted in full.
  • · Payment was made on April 17, 2026, based on unaudited NAV as of March 31, 2026.
  • · One Class D, 15 Class Y, one Class I, and 416 Class Z shareholders tendered their entire holdings.
Virtus Dividend, Interest & Premium Strategy Fund SC TO-I/A neutral materiality 3/10

03-09-2026

Virtus Dividend, Interest & Premium Strategy Fund (NFJ) filed Amendment No. 1 to its Schedule TO on September 3, 2026, amending the issuer tender offer originally filed on September 1, 2026. The amendment adds a press release dated September 1, 2026, as an exhibit. The tender offer is an issuer self-tender under Rule 13e-4, and the Fund previously entered into a standstill agreement with Virtus Investment Advisers and Saba Capital Management on April 17, 2026.

  • · The filing is an amendment (No. 1) to the initial Schedule TO filed on September 1, 2026.
  • · The amendment adds a press release dated September 1, 2026, as an exhibit.
  • · The tender offer is an issuer self-tender under Rule 13e-4, not a third-party or going-private transaction.
  • · A standstill agreement was previously entered into on April 17, 2026, among Virtus Investment Advisers, the Fund, and Saba Capital Management.
  • · The filing does not report final results of the tender offer (no check in the final amendment box).
Apogee Therapeutics, Inc. 25-NSE negative materiality 9/10

03-09-2026

Apogee Therapeutics, Inc. (APGE) filed a Form 25-NSE with the SEC on September 3, 2026, notifying the delisting of its common stock from the Nasdaq Stock Market. The delisting is pursuant to Rule 12d2-2(a)(3) of the Securities Exchange Act of 1934, indicating the company has complied with Nasdaq's delisting procedures. This action removes the company's securities from trading on Nasdaq, which may have significant implications for liquidity and shareholder value.

  • · Filing type: 25-NSE (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934)
  • · SEC file number: 001-41740
  • · Central Index Key (CIK): 0001974640
  • · Effectiveness date: September 3, 2026
  • · Delisting rule cited: 17 CFR 240.12d2-2(a)(3) (voluntary or involuntary delisting by exchange)
  • · Company address changed from San Francisco to Waltham, Massachusetts (221 Crescent St, Building 17, Suite 102b, Waltham, MA 02453)
  • · Former name: Apogee Therapeutics, LLC (name change date: April 20, 2023)
Private Debt & Income Fund SC TO-I/A neutral materiality 5/10

03-09-2026

Private Debt & Income Fund filed a final amendment to its tender offer, reporting that 264,813.73 Class I Shares were validly tendered and repurchased for $6,649,472.81, representing approximately 5% of net assets ($466,872,313.20 as of April 30, 2026). The offer expired on July 30, 2026, with payments made on August 18 and August 26, 2026. The repurchase price was based on a net asset value of $25.11 per share as of the June 30, 2026 valuation date.

  • · Tender offer expired on July 30, 2026, at 11:59 p.m. Eastern Time.
  • · Valuation date was June 30, 2026, with NAV of $25.11 per share.
  • · Payments were made in two tranches: on or about August 18, 2026, and August 26, 2026.
  • · The offer was for up to 5% of net assets, and 100% of the tendered shares were accepted.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 42 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Global High-Priority Regulatory Events

🇺🇸 More from United States

View all →